We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+5.26%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$57.2B
AUM Growth
+$551M
(+0.97%)
Cap. Flow
-$331M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
31.76%
Holding
1,006
New
143
Increased
295
Reduced
385
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$247M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$183M |
| 3 |
WCC
WESCO International
WCC
|
+$178M |
| 4 |
Gilead Sciences
GILD
|
+$154M |
| 5 |
Delta Air Lines
DAL
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$221M |
| 2 |
3M
MMM
|
+$157M |
| 3 |
MRSH
Marsh
MRSH
|
+$120M |
| 4 |
Johnson & Johnson
JNJ
|
+$106M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.09% |
| 2 | Healthcare | 13.87% |
| 3 | Financials | 11.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Industrials | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Veru
VERU
$37.4M
| $1.5M | ﹤0.01% |
230,000
-556,111
| -71% | -$4.13M |
|
802
Moog Inc Class A
MOG.A
$12.9B
| $1.49M | ﹤0.01% |
7,553
| – | – |
|
803
Werner Enterprises
WERN
$2.27B
| $1.46M | ﹤0.01% |
40,545
| – | – |
|
|
SLRN
804
DELISTED
ACELYRIN
SLRN
| $1.41M | ﹤0.01% |
450,000
-95,476
| -18% | -$462K |
|
805
Immunic
IMUX
$191M
| $1.4M | ﹤0.01% |
139,860
-419,581
| -75% | -$5.29M |
|
806
Arcutis Biotherapeutics
ARQT
$3.39B
| $1.39M | ﹤0.01% |
+100,000
| New | +$1.1M |
|
|
CIVI
807
DELISTED
Civitas Resources
CIVI
| $1.38M | ﹤0.01% |
30,000
-145,000
| -83% | -$7.22M |
|
|
ORKA
808
Oruka Therapeutics
ORKA
$5.86B
| $1.34M | ﹤0.01% |
69,200
-130,800
| -65% | -$3.19M |
|
|
IMA
809
ImageneBio Inc
IMA
$65.4M
| $1.31M | ﹤0.01% |
66,667
-15,658
| -19% | -$317K |
|
|
CBIO
810
Crescent Biopharma
CBIO
$586M
| $1.27M | ﹤0.01% |
+50,912
| New | +$1.39M |
|
811
Old Second Bancorp
OSBC
$1.32B
| $1.24M | ﹤0.01% |
+69,987
| New | +$1.22M |
|
812
Lifestance Health
LFST
$3.96B
| $1.18M | ﹤0.01% |
160,000
| – | – |
|
|
MOFG
813
DELISTED
MidWestOne Financial Group
MOFG
| $1.14M | ﹤0.01% |
39,085
-110,915
| -74% | -$3.39M |
|
814
Match Group
MTCH
$8.9B
| $1.13M | ﹤0.01% |
34,616
-58,500
| -63% | -$2M |
|
815
Option Care Health
OPCH
$3.55B
| $1.07M | ﹤0.01% |
46,000
-15,000
| -25% | -$379K |
|
816
Community Trust Bancorp
CTBI
$1.43B
| $1.06M | ﹤0.01% |
+20,000
| New | +$1.1M |
|
817
Palladyne AI
PDYN
$282M
| $1.02M | ﹤0.01% |
83,333
| – | – |
|
818
Liquidia Corp
LQDA
$7.93B
| $992K | ﹤0.01% |
+84,376
| New | +$922K |
|
819
Instil Bio
TIL
$49.2M
| $955K | ﹤0.01% |
+50,000
| New | +$1.52M |
|
820
Selective Insurance
SIGI
$5.76B
| $935K | ﹤0.01% |
+10,000
| New | +$958K |
|
821
Ovid Therapeutics
OVID
$489M
| $934K | ﹤0.01% |
+1,000,000
| New | +$1.12M |
|
822
Surrozen
SRZN
$255M
| $928K | ﹤0.01% |
+64,653
| New | +$686K |
|
823
Lifezone Metals Ltd Warrants
LZM.WS
$29.3M
| $907K | ﹤0.01% |
1,231,797
| – | – |
|
|
QXO
824
QXO Inc
QXO
$17.2B
| $797K | ﹤0.01% |
50,148
| – | – |
|
825
HealthEquity
HQY
$8.73B
| $768K | ﹤0.01% |
+8,000
| New | +$745K |
|
Similar funds
Adage Capital Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Adage Capital Partners held 1,006 positions worth $57.2B, up 0.97% from $56.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Adage Capital Partners's Q4 2024 filing shows 143 new, 295 increased, 385 reduced and 137 closed positions. Its largest new stake was Gilead Sciences: 1,714,130 shares worth $158M. The largest sale was Marathon Oil Corporation, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q4 2024 buy was Gilead Sciences: 1,714,130 shares worth $158M.
- Adage Capital Partners added most to ConocoPhillips in Q4 2024, an estimated $247M increase.
- Adage Capital Partners's biggest Q4 2024 reduction was 3M, cutting an estimated $157M.
- Adage Capital Partners fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $221M.
- Adage Capital Partners's ten largest holdings make up 32% of its $57.2B portfolio in Q4 2024.
- Adage Capital Partners opened 143 new positions and closed 137 in Q4 2024.
- Adage Capital Partners's portfolio value rose 0.97% quarter-over-quarter to $57.2B.
Based on Adage Capital Partners's 13F filing for Q4 2024, filed 14 Feb 2025.